ArticleScience translational medicine2020

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome.

Patrick K McCamphill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.